MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Sep 18, 04:59 PM (EDT)
Price
$410.00
Change
+$6.32 (+1.57%)
Capitalization
18B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UTHR with price predictions
Sep 17, 2025

Aroon Indicator for UTHR shows an upward move is likely

UTHR's Aroon Indicator triggered a bullish signal on September 11, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 272 similar instances where the Aroon Indicator showed a similar pattern. In of the 272 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 17, 2025. You may want to consider a long position or call options on UTHR as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UTHR just turned positive on September 02, 2025. Looking at past instances where UTHR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for UTHR crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTHR advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for UTHR moved out of overbought territory on September 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where UTHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UTHR broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.545) is normal, around the industry mean (17.169). P/E Ratio (15.750) is within average values for comparable stocks, (74.138). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.888). UTHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (6.353) is also within normal values, averaging (46.994).

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 14.04% to $7.31 per share on October 29

United Therapeutics Corp UTHR Stock Earnings Reports
Q3'25
Est.
$7.31
Q2'25
Missed
by $0.94
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
The last earnings report on July 30 showed earnings per share of $6.41, missing the estimate of $7.35. With 201.93K shares outstanding, the current market capitalization sits at 18.00B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BERZ4.000.05
+1.27%
MicroSectors™ St FANG&Inn 3X Inv Ld ETNs
BGH16.800.06
+0.36%
Barings Global Short Duration High Yield Fund
MAYW32.88N/A
+0.01%
AllianzIM U.S. Large Cp Buffer20 May ETF
BTT22.55N/A
N/A
BlackRock Municipal 2030 Target Term Trust
SECR26.34-0.02
-0.07%
NYLI MacKay Securitized Income ETF

UTHR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+1.43%
MNKD - UTHR
38%
Loosely correlated
+0.56%
GERN - UTHR
37%
Loosely correlated
+2.00%
DAWN - UTHR
37%
Loosely correlated
-1.69%
ALNY - UTHR
36%
Loosely correlated
-2.06%
CBIO - UTHR
36%
Loosely correlated
+1.84%
More

Groups containing UTHR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+1.43%
Pharmaceuticals: Generic
industry (221 stocks)
30%
Poorly correlated
+0.55%
Pharmaceuticals
industry (385 stocks)
23%
Poorly correlated
+0.57%